FIELD: organic chemistry.
SUBSTANCE: group of inventions includes a compound of formula (IV), its salt, a pharmaceutical composition containing it, and its use. In formula (IV), R7 is selected from C1-C6alkyl, optionally substituted with a 5-membered heteroaryl selected from furyl or thienyl, or a six- to 10-membered aryl, which is optionally substituted with halogen; C3-C8cycloalkyl, which can be fused with phenyl and is optionally substituted with hydroxyl, C1-C6alkoxy, phenyl optionally substituted with 1–2 halogen atoms, or where R15 represents C1-C6alkyl; A C3-C8 unsaturated hydrocarbon ring substituted with a -COOR17 group, where R17 represents a C1-C6alkyl; groups where R14 is selected from the group consisting of H, C1-C6alkyl and -Boc; 5-membered heterocyclyl containing 1–2 nitrogen atoms condensed with phenyl; 5-membered heteroaryl containing 2 nitrogen atoms fused with phenyl; and groups.
(IV)
EFFECT: compound of formula (IV) with inhibitory activity against NAE.
8 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
5-AROMATIC ALKYNYL-SUBSTITUTED BENZAMIDE COMPOUND AND METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2016 |
|
RU2695371C2 |
METHOD FOR SYNTHESIS OF NOVEL CHIRAL LIGAND, METAL CHELATE, VARIOUS UNNATURAL AMINO ACIDS, MARAVIROC AND MAIN INTERMEDIATE COMPOUNDS THEREOF | 2017 |
|
RU2727723C1 |
DERIVATIVE BASED ON DIHYDROPYRIMIDO-RING AS HBV INHIBITOR | 2015 |
|
RU2693897C2 |
AMYLOID-BINDING AGENTS | 2010 |
|
RU2517174C2 |
PYRIMIDO[5,4-B]INDOLIZINE OR PYRIMIDO[5,4-B]PYRROLIZINE COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2721774C1 |
FLUORINATED COMPOUND OF CYCLOPROPYLAMINE, THE METHOD OF PREPARATION, THE PHARMACEUTICAL COMPOSITION AND ITS USE | 2017 |
|
RU2746323C2 |
NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 |
|
RU2729999C1 |
COMPOUNDS BASED ON 7-SUBSTITUTED PYRROLOTRIAZINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHODS FOR THEIR PREPARATION AND APPLICATION | 2018 |
|
RU2745548C1 |
DERIVATIVES OF NOR-SECO-CHIMBACINE, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING BASED ON THEREOF | 2001 |
|
RU2293735C2 |
Authors
Dates
2023-12-19—Published
2020-06-12—Filed